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Set up quality control circles to reduce the incidence of hematoma caused by
subcutaneous injection of low molecular heparin calcium
Guan He, Wen Chengfei
First Hospital of Jilin University
Objectives: Through quality control circle activity to reduce the incidence of
hematoma caused by subcutaneous injection of low molecular heparin calcium.
Methods: We retrospectively analyzed 256 patients with subcutaneous injection of
low molecular heparin calcium hospitalized in our department in June to
September, 2013, including 43 cases occurred hematoma after injection, the
incidence was 16.8%.In October 2013, we set up QCC activity group (quality
control circle, QCC), RCA analysis was carried out on the complications, we
determined the nursing problems, nursing plan according to the reasons. Measures
include: (1) Reengineer the process, (2) Standard operating procedures, (3)
Improve operation skills, ① Indwelling bubble technique: indwelling 0.1 ml
bubbles before injection can effectively control the invalid cavity, avoid liquid
inﬁltration into the subcutaneous after pulling needle, and reduce the incidence of
hematoma. ② The injection site: the abdomen is divided into four quadrants ac-
cording to the cross division method. Injection sites were 5 cm above the umbi-
licus, 5 cm below the umbilicus, umbilical about 10 cm (except periumbilical 2
cm), Take turns to inject, avoid scleroma and ecchymosis and formulate the special
injection site formula. ③ Vertical injection: It can effectively promote drug
absorption and reduce the damage to the subcutaneous tissue and blood capillary. ④
Withdraw blood injection: the advisable injection speed is 30s, Too fast injection
may cause bleeding, Too slow injection may aggravate patient pain caused by a
long time needle retention in the body. ⑤ Press method and time: when we pull out
the needle, guide patients to use two ﬁngers pressing subsidence 2 cm on the
skin for 10 min, If the patient have extended blood coagulation time or a large
number of application of anticoagulant drugs, press time should be appropriately
extended. (4) Avoid needle stick injuries, (5) Strengthen the drug health propa-
ganda and education. For example, paste posters to strengthen the consciousness of
patients in the ward. (6) Hold QCC activity meetings at regular intervals, (7)
Regular subcutaneous injection of low molecular heparin calcium operation
training for nurses.
Results: Six months after the implementation of QCC, hematoma formation rate
in patients with subcutaneous injection of low molecular heparin calcium was 7%,
the occurrence rate of hematoma was reduced by 42% compared to review data
results.
Conclusions: The QCC activity decreased the incidence of hematoma in patients with
subcutaneous injection of low molecular heparin calcium after PCI.
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Two birds with one stone: a-blocker therapy on LUTS/BPH in men concomitant
with mild hypertension
Xiao Hengjun1, Pang Jun1, Hu Cheng1, Wu Jieying1, Chen Jun2, Pu Xiaoyong3,
Li Dong3, Gao Xin1
1Department of Urology, The Third Afﬁliated Hospital of SUN Yat-Sen University,
Guangzhou, 2Department of Infertility & Sexual Medicine, The Third Afﬁliated
Hospital of SUN Yat-Sen University, Guangzhou, 3Department of Urology,
Guangdong Provincial People’s Hospital, Guangzhou
Objectives: To assess the clinical efﬁcacy and safety of administering doxa-
zosin as an alpha (1)-blocker in patients with comorbid LUTS/BPH and mild
hypertension.
Methods: 156 enrolled men concomitant with comorbid LUTS/BPH and mild hy-
pertension who completed the International Prostate Symptom Score (IPSS >7 points)
at the ﬁrst visit in our clinic were eligible in this trial. All the patients were assessed
based on IPSS, IPSS-Quality of Life for LUTS/BPH and received blood pressure (BP)
determination. Those men with normotensive and moderate-to-severe hypertension
were excluded. Urologic and cardiologic assessment included uroﬂowmetry
(maximum urinary ﬂow rate, Qmax), IPSS, and blood pressure measurements. They
were administered with 4mg of doxazosin once daily for 12 weeks. Changes of IPSS,
Qmax, Quality of Life for LUTS/BPH, systolic and diastolic blood pressure were
evaluated every 4 weeks. Safety was mainly assessed via spontaneous reports of
adverse events.
Results: After treatment with doxazosin, IPSS in those LUTS/BPH men signi-
ﬁcantly decreased (15.24.8 vs 10.73.5 points, P<0.001), whereas Qmax
increased (9.42.5 and 11.84.3 mL/s, P<0.01), respectively. Doxazosin
demonstrated efﬁcacy in lowering IPSS score and relieving LUTS. Of them,
systolic and diastolic blood pressure of 124 patients (79.5%) decreased to
normal. Most patients were generally well tolerant to the treatment and there
was no evidence of additional side effects related to administration. No orthostatic
hypotension and other blood pressure-related adverse proﬁles occurred in all
patients.
Conclusions: Our data show that doxazosin as an alpha (1)-blocker treatment
appears to be efﬁcacious in both relieving bothersome lower urinary tract symptoms
and decreasing blood pressure in LUTS/BPH men with mild hypertension.
This work was supported by Fundamental Research Funds for the Central Uni-
versities (12ykpy40), Guangdong Provincial Science and Technology Program
(2011B060300003).C242 JACC VolGW25-e0587
Research on the clinical application of ultrasound-guided catheterization of
deep-vein in cardiac surgical patients
Shan Reai, Yuan Liuqing
Department of Anesthesiology, First Afﬁliated Hospital of Gannan Medical College
Objectives: To research the clinical value of the application of ultrasound-guided on
deep-vein catheterization in cardiac surgical patients.
Methods: 100 cases with Jugular vein used ultrasound-guided catheterization were
enrolled in this study. The time of insertion, a success rate of catheter and the inci-
dence of complications were analyzed respectively.
Results: In Jugular vein puncture group, the one puncturation and intubation success
rate with ultrasound-guided catheterization and traditional blind catheterization was
96% (48/50) and 64% (32/50, P<0.05) respectively. The complication rate was
0 (0/50) and 8% (4/50, P<0.05) respectively.
Conclusions: Ultrasound-guided catheterization in the deep-vein puncture is surpass
to traditional blind catheterization. It is high success rate, and can avoid complication,
has great clinical value.
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Research to improve nursing execution in “quality control circle” activities
Wen Chengfei, Ma Xinlei, Liu Yue
The First Hospital of Jilin University
Objectives: Gradually improve the nurses’ execution by management in the QCC
activities, so as to better implement various systems and processes, improve the
nursing quality and working efﬁciency.
Methods: (1) Organizing training:Sending someone to learn relevant knowledge and
organizing nurses to learn characteristics, activities principles and methods of QCC.
Making nurses have full understanding of QCC quality management. (2) Establish-
ment of evaluation:Establishing the Nurse Competion Table, Nurses’ execution of
QCC will be closely integrated with nurse appraised. Selecting the best QCC exec-
utive team when we ﬁnish the building. (3) One point to surface: after dividing into
groups, every leader led the members practice various exercises, convey the spirit of
QQC, promote the practice, supervise the system and implement, feedback timely. (4)
Everyone involved in the management: Each leader is responsible for the problem
analyzed, the measures proposed, results tracking and continuous improvement at
different stages. (5) Wechat meeting: Making the meeting form is different. Using
brainstorm ways, it can make meetings convenient and time-saving, it also can
improve participants’ enthusiasm. By establishing equality and mutual working
relationship and management guidance mode, Enable members to work in a more
positive atmosphere. (6) Self check before doing: The teams are given sufﬁcient time
to self-check and correct before the problems implementing. After self check, carry
out snap check. (7) Sampling check regularly: Counselor and team leader take the
action of group supervision, no punishment rating system between groups, ﬂow using
sampling check regularly, dynamic scoring position, ensure quality of care continued
to improve, if problems found, timely group discussion. (8) Transparent result:
Sampling observation results of each group must be published in time. For all the
indicators which need to be optimized must provide development trends, all the
members must draw fully attention. (9) Team motivation: Encourage team morale by
regular meetings. Emphasis on the goals and objectives of the QCC before the
meetings. Let us realize the current stage of QCC, achievements and gaps, overcome
fatigue and keep in relaxed mood. (10) PDCA circle: Ensure that management means
of QCC connected, making full use of the PDCA circle, promoting executive power of
nurses steady rapidly improvement.
Results: By implementing all the above measures and using checklists for sampling,
the results showed the nurse executive power increased from 86% to 95%, and it also
inspired the members’ enthusiasm, patient satisfaction, the members’ innovation
capacity are all improved.
Conclusions: The approach of QCC management is to give nurses sense of re-
sponsibility in the management process, effectively tap the potential of nursing
management, achieve full participation in quality management to increase their value.
The above measures are effective to improve the execution power of nurses in QCC
activities, can be extended.
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Vascular protective effects of early HRT on ovariectomized in female rats
and research on the molecular mechanism preliminarily
Rao Kunrui, Wang Xue, Zheng Xiaopu
Medical School of Xi’an Jiaotong University
Objectives: The purpose of the present study was to observe the effect of ealy and late
hormone replacement therapy (HRT) on vascular functions in ovariectomized female
rat models, and to study on the molecular mechanism preliminarily.
Methods: The ovariectomized models were established by removing ovaries in female
rats and were divided to early group and late group.There were three groups including
sham operation group, ovariectomized model group and HRT group in the early group
and the late group. Firstly, we deteced the relaxation to acetylcholine (Ach) and so-
dium nitroprusside (SNP) in isolated thoracic aorta. Next, the morphology of aorta
was observed by transmission electron microscope.Furthermore, the serum level of64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Others
NO was checked by nitrate reductase assay, the activity of inducible nitric oxide
synthase ( iNOS ) was determined using iNOS assay kit.
Results: In the early group, the relaxation response to ACh was increased signiﬁcantly
in HRT group than that in ovariectomized model group, while there was no difference
in the relaxation response to ACh between HRT group and ovariectomized model
group in the late group. And there were no difference in the relaxation response to
SNP between HRT group and ovariectomized model group in the early group and the
late group; In the early group, transmission electron microscopy images of aorta in
HRT group presented no swelling of endothelial cells, no vacuoles in tracytoplasmic,
successive internal elastic lamina, endothelial cells attachment to elastic plate closely
and regularly arranged smooth muscle cells compared to that in ovariectomized early
group. However, there was no difference in transmission electron microscopy images
between HRT group and ovariectomized model group in the late group; In the early
group, the serum level of NO increased markedly in HRT group compared to the
ovariectomized model group. In the late group, the serum level of NO in HRT group
was similar to ovariectomized model group; There were no obvious changes in aortic
iNOS content between HRT group and ovariectomized model group in the early group
as well as in the late group.
Conclusions: HRT improved endothelial destruction and endothelial-dependent
vasodilation in the early HRT model, which related to nitric oxide release from
endothelial cells. Aortic iNOS content didn’t increased with the extension of ovari-
ectomized time, and didn’t increased by HRT in the early group as well as in the late
group.
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Resveratrol supplementation was not beneﬁcial to the anti-inﬂammatory effects
and metabolic modulation in the prevention of cardiovascular disease and stable
coronary artery disease: A meta-analysis
Yan Rui1, Lin Lin1, Shan Hu1, Zhang Ming3, He Le2, Wei Jin1
1Department of Cardiology, The Second Afﬁliated Hospital, Xi’an Jiaotong University
School of Medicine, Xi’an, Shaanxi, China, 2Department of Internal Medicine, Xi’an
No.5 Hospital, Xi’an, Shaanxi, China, 3Department of Respiratory Medicine, The
Second Afﬁliated Hospital, Xi’an Jiaotong University School of Medicine, Xi’an,
Shaanxi, China
Objectives: To explore the effects of resveratrol on the anti-infammatory and meta-
bolic modulation in the prevention of cardiovascular disease and stable coronary ar-
tery disease.
Methods: A systematic literature search was conducted to identify randomised
controlled trials of resveratrol in Pubmed. Reports of trials were sought that evaluated
the effects of reseratrol in patients with cardiovascular disesase risk factors and stable
coronary artery disease .Then according to the Cochrane Handbook for systematic
reviews, we estimate the qulity of the randomised controlled trials and collect the
useful information. At last, we choose the variable and process data with RevMan 5.0.
Results: 12 trials with data for 455 patients were identiﬁed by the literature search.
Resveratrol did not signiﬁcantly decrease the CRP (weighted mean difference (WMD)
-0.12mg/L, 95% CI -0.36 to 0.12, P>0.05), TNF-a (WMD -0.09pg/mL, 95% CI
-0.53-0.35, P>0.05), and IL-6 (WMD 0.01pg/mL, 95% CI -0.23-0.24, P>0.05) in
patients compared with placebo. But resveratrol could decrease IL-1b in the pool
analysis of 2 clinical trials with WMD -0.17pg/mL, 95% CI -0.27 -0.08, P<0.05. The
reveratrol supplementation brought some beneﬁts on glycemic control, which per-
formed the ability of reducing the HbA1c (WMD 0.08%, 95% CI 0.04-0.12, P<0.05),
however it was a pity that reveratrol could not improve the fasting glucose (WMD
0.03mmol/L, 95% CI from -0.04 to 0.10, P>0.05), even increased homeostasis model
of assesment of insulin resistance (WMD 0.88, 95% CI 0.77-0.98, P<0.05) and in
patients with high cardiovascular risk but without diabetes compared with placebo. At
the same time, the supplementation of resveratrol did not exert the signiﬁcant effect on
the secretion of leptin (WMD -0.49ng/mL, 95% CI -1.49-1.97, P>0.05) and adipo-
nectin (WMD 0.13ug/mL, 95% CI -0.23 to 0.48, P>0.05).
Conclusions: According to the existed evidences, resveratrol supplementation did not
bring beneﬁts on the metabolic modulation and anti- inﬂammatory effects. Then
because of the number of clinical trials and the samples of these reports were small, we
need more large and multicenter to clarify the effects of resveratrol on cardiovascluar
protection.
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Plasma homocysteine levels in patients with subclinical hypothyroidism:
A meta-analysis
Ma Kai1, Liu Fangfang2, Chen Shaohua2, Liu Yanan3, Zhang Wei2
1Qingdao University Medical College, Qingdao, 266021, China, 2Department of
Endocrinology, Shandong Provincial Qianfoshan Hospital afﬁliated to Shandong
University, Jinan, 250014, China, 3The First People’s Hospital of Jinan, Jinan,
250011, China
Objectives: Hyperhomocysteinemia is a well known risk factor for cardiovascular
disease. However, although increased plasma homocysteine levels have been widely
documented in overt hypothyroidism patients, their changes in subclinical hypothy-
roidism (SCH) patients remains controversial: a few of studies have shown that tHcy
level is elevated in SCH, while the others are conﬂicting. The aim of this meta-
analysis is to review the current data available in an effort to determine the associationJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Obetween SCH and hyperhomocysteinemia, as well as associations between SCH and
various metabolic/cardiovascular risk factors.
Methods:We searched PUBMED, EMBASE and COCHRANE LIBRARY databases
prior to September 2013 to identify studies that reported plasma homocysteine levels
in patients with SCH compared with euthyroid subjects. Two reviewers independently
evaluated every potential study for eligibility, assessed the methodological quality,
and extracted the data. Most of the included articles are observational studies, so we
conducted and reported this analysis according to the guidelines of the Meta-analysis
of Observational Studies in Epidemiology Group. We extracted the mean level as well
as the standard deviation of tHcy in SCH and euthyroid subjects from each study. All
the statistical analysis in this study was performed by using STATA 12 (Stata, College
Station, Texas, 77845 USA). The weighted mean difference (WMD) and 95% CIs of
tHcy, folate and vitamin B12, as well as some metabolic parameters such as BMI,
FPG, TG, HDL, LDL-C, were calculated in each study.
Results: We ﬁnally included nine studies with 443 patients and 367 controls from 33
articles in this meta- analysis. The pooled result of the weighted mean difference
(WMD) of increased tHcy levels was 0.96 mmol/L (95% CI 0.14-1.78; P¼0.022). And
the analysis of metabolic parameters showed that SCH was associated with a signif-
icant increase of body mass index (WMD, 1.331.33 kg/m2, 95% CI 0.62-2.04;
P<0.01), systolic blood pressure (WMD, 10.89 mmHg, 95% CI 6.55, 15.23; P<0.01),
diastolic blood pressure (WMD, 7.20mmHg, 95% CI 5.02-9.37; P<0.01), triglyceride
levels (WMD, 0.32 mmol/l, 95% CI 0.19-0.64; P<0.01), total cholesterol levels
(WMD, 0.53 mmol/l, 95% CI 0.36, 0.71; P<0.01), and low-density lipoprotein levels
(WMD, 0.28 mmol/l, 95% CI 0.14-0.42; P<0.01). Though the analysis of folate
showed lack of statistical difference, there was a decrease tendency in SCH patients
(WMD, -0.55ng/ml, 95% CI -1.10-0.00; P¼0.051). Other parameters such as HDL
(WMD, -0.04mmol/l, 95% CI -0.09-0.02; P¼0.178), vitamin B12 (WMD, -1.90pg/ml,
95% CI -23.93-20.13; P¼0.723), there are no signiﬁcant differences between the two
groups. While for vitamin B6, we could not perform an analysis since the enrolled
studies did not provide sufﬁcient data to calculate the 95% CI of vitamin B6 levels. As
the data provide in each study is insufﬁcient, we could not analyze the associations
between the homocysteine levels and these parameters.
Conclusions: Our analysis of nine observational studies with 443 patients showed that
SCH is associated with an increased plasma homocysteine levels. As for other
traditional risk factors for CVD, SCH is associated with a signiﬁcant increase in BMI,
SBP, DBP, TG, TC and LDL-C. And given to the higher risk of coronary artery
disease, all these ﬁndings emphasize the necessity of earlier screening and treating of
SCH.
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Correlation of CYP2C19 gene polymorphism and coronary heart disease in
Yunnan Han population
Zhang Liguo, Zhuo Yu
First Afﬁliated Hospital of Kunming Medical University
Objectives: Cytochrome P450 (CYP) 2C19 gene polymorphism and coronary heart
disease in Yunnan Han population correlation.
Methods: Randomly selected from September 2012 to December 2013 at the First
Afﬁliated Hospital of Kunming Medical College of Cardiology hospital and unrelated
Yunnan Han population 127 cases for the study, microarray assay using blood sam-
ples selected in the CYP2C19 gene sequence DNA single nucleotide polymorphisms
(single nucleotide polymorphism, SNP) genotype CYP2C19*1, CYP2C19*2,
CYP2C19*3, analysis of genotype and allele frequencies, realize the feature of
CYP2C19 polymorphisms inYunnan Han population; To be divided the population
into three classes (extensive metabolisers, intermediate metabolizers, and poor
metabolizers) by the basis of metabolic phenotype deﬁnition and the result of geno-
type. Group of 63 patients with coronary artery disease and 64 patients in the control
group to analyze the genetic polymorphisms, analyze the correlation of gene poly-
morphism and coronary heart disease.
Results: Genetic analysis: CYP2C19 genotype is given priority to with wild type in
Yunnan Han population, CYP2C19*1, CYP2C19*2 and CYP2C19*3 3 alleles fre-
quency of occurrence was 66.9%, 28.4% and 4.7%;Of CYP2C19 metabolic pheno-
type deﬁnition intermediate metabolizers highest frequency (47.2%), followed by
extensive metabolisers (43.3%), poor metabolizers (9.5%) the lowest; CYP2C19*1/
*1, CYP2C19*1/*2, CYP2C19*1/*3, CYP2C19*2/*2, CYP2C19*2/*3 and
CYP2C19*3/*3 genotype frequency was 43.3%, 42.5%, 4.7%, 5.5%, 3.2% and 0.8%.
Two groups of CYP2C19 genotype distribution accords with Hardy Weinberg equi-
librium; CYP2C19*1, CYP2C19*2, CYP2C19*3 allele in CHD group were 56.3%,
37.3%, 6.4%, in the control group were 77.3%, 19.5%, 3.2%, Allele frequency dis-
tribution between the two groups was statistically difference (P<0.05); CYP2C19*1/
*1, CYP2C19*1/*2, CYP2C19*1/*3, CYP2C19*2/*2, CYP2C19*2/*3 and
CYP2C19*3/*3 genotype in the CHD group were 25.4%, 55.6%, 6.3%, 7.9%, 3.2%
and 1.6%, in the control group was 60.9%, 29.8%, 3.1%, 3.1%, 3.1% and 0, between
the two groups genotypes were statistically difference (P<0.05); Logistic regression
analysis: In addition to traditional risk factors after age, sex, hypertension, diabetes,
high cholesterol, etc., CYP2C19*1/*2 gene mutation signiﬁcantly increased risk of
coronary heart disease (OR¼5.24, 95% CI 2.00-13.72), CYP2C19*1/*3 gene muta-
tion was also signiﬁcantly increased the risk (OR¼4.54, 95% CI 0.55-37.08).
CYP2C19 polymorphism is an important risk factor for coronary heart disease in
Yunnan Han population.
Conclusions: CYP2C19 polymorphism may increase the risk of coronary heart
disease in Yunnan Han population.thers C243
